Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: A single centre feasibility study

Hay, L. K. et al. (2020) Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: A single centre feasibility study. Technical Innovations and Patient Support in Radiation Oncology, 14, pp. 21-29. (doi: 10.1016/j.tipsro.2020.02.004) (PMID:32226833) (PMCID:PMC7093804)

[img]
Preview
Text
212791.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

1MB

Abstract

Objectives: The study aimed to assess the suitability of deformable image registration (DIR) software to generate synthetic CT (sCT) scans for dose verification during radiotherapy to the head and neck. Planning and synthetic CT dose volume histograms were compared to evaluate dosimetric changes during the treatment course. Methods: Eligible patients had locally advanced (stage III, IVa and IVb) oropharyngeal cancer treated with primary radiotherapy. Weekly CBCT images were acquired post treatment at fractions 1, 6, 11, 16, 21 and 26 over a 30 fraction treatment course. Each CBCT was deformed with the planning CT to generate a sCT which was used to calculate the dose at that point in the treatment. A repeat planning CT2 was acquired at fraction 16 and deformed with the fraction 16 CBCT to compare differences between the calculations mid-treatment. Results: 20 patients were evaluated generating 138 synthetic CT sets. The single fraction mean dose to PTV_HR between the synthetic and planning CT did not vary, although dose to 95% of PTV_HR was smaller at week 6 compared to planning (difference 2.0%, 95% CI (0.8 to 3.1), p = 0.0). There was no statistically significant difference in PRV_brainstem or PRV_spinal cord maximum dose, although greater variation using the sCT calculations was reported. The mean dose to structures based on the fraction 16 sCT and CT2 scans were similar. Conclusions: Synthetic CT provides comparable dose calculations to those of a repeat planning CT; however the limitations of DIR must be understood before it is applied within the clinical setting.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Duffton, Aileen and McLoone, Mr Philip and Paterson, Dr Claire and Grose, Dr Derek and James, Dr Allan and Schipani, Dr Stefano and Valentine, Mr Ronan
Authors: Hay, L. K., Paterson, C., McLoone, P., Miguel-Chumacero, E., Valentine, R., Currie, S., Grose, D., Schipani, S., Wilson, C., Nixon, I., James, A., and Duffton, A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Public Health
College of Medical Veterinary and Life Sciences > Institute of Molecular Cell and Systems Biology
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Technical Innovations and Patient Support in Radiation Oncology
Publisher:Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology
ISSN:2405-6324
ISSN (Online):2405-6324
Copyright Holders:Copyright © 2020 The Authors
First Published:First published in Technical Innovations and Patient Support in Radiation Oncology 14:21-29
Publisher Policy:Reproduced under a Creative Commons Licence

University Staff: Request a correction | Enlighten Editors: Update this record